The program is a part of the Seegene OneSystemTM business aimed at creating a ‘world free from all diseases’ Collaborating with clinical researchers worldwide, Seegene will share its technologies and enable researchers to develop syndromic qPCR assays SEOUL, South Korea, Sept. 4, 2023…